An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.

Launched by NEW WORLD MEDICAL, INC. · Jan 19, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the long-term safety and effectiveness of a special device called the STREAMLINE® SURGICAL SYSTEM for patients with open-angle glaucoma, a condition that affects the pressure in the eye. If you participated in a previous study, called DF6-CL-20-01, you may be eligible to join this new trial. It is important to note that if you were lost to follow-up in the earlier study, you won’t be able to participate.

In this trial, participants will have the chance to continue monitoring their eye health and see how well the STREAMLINE® device works over a longer period. The study is not currently recruiting participants, but it will open up for enrollment soon. If you or a family member are interested, you can keep an eye out for updates about when it starts. Your involvement could help improve treatments for glaucoma in the future!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • participated in the DF6-CL-20-01 trial.
• Exclusion Criteria:
• • lost to follow up in the DF6-CL-20-01 trial